Aarhus University Seal / Aarhus Universitets segl

Virtual PhD defence: Anders Sjørslev Schmidt

Cardioversion of atrial fibrillation

2021.03.17 | Graduate School of Health

Date Fri 09 Apr
Time 13:00 15:00
Location Online via Zoom

On Friday 9 April at 13.00, Anders Sjørslev Schmidt defends his "Improving the efficacy and safety of direct current cardioversion".

Atrial fibrillation is the most common cardiac arrhtyhmia. The lifetime risk of atrial fibrillation is estimated to be 1 in 3 individuals. Atrial fibrillation is associated with other common lifestyle diseases such has hypertension and increases the risk of myocardial infarction and stroke. Direct-current cardioversion is a commonly performed procedure in the management of atrial fibrillation. This PhD project consisted of three randomized clinical trials. The aim of the trials was to investigate three clinical questions: Which devices, energy settings and electrode positions are resulting in the most successful outcome after cardioversion? The trials have contributed with important new evidence, which is directly useful for nurses and doctors as to guide clinical practise.

The summary is written by the PhD student.    

The defence is public and takes place online via Zoom. Please read the attached press release for more information.


PhD student Anders Sjørslev Schmidt

Mail: as@clin.au.dk 

Phone: (+45) 21243181

Read full press release

PhD defense, Public/Media, Health, Graduate School of Health, PhD students, Graduate School of Health, Academic staff, Department of Clinical Medicine